Your search for dabigatran returned 105 results

The researchers found the risk of GI bleeding was lower for apixaban versus dabigatran or rivaroxaban.

Compared with other DOACs, rivaroxaban linked to higher rates of GI bleeding overall and in an analysis restricted to patients with atrial fibrillation

Efficacy similar to aspirin for preventing recurrent stroke after embolic stroke of undetermined source

The study analyzed data from NVAF patients newly initiating treatment with dabigatran, rivaroxaban or apixaban.

At ACC.13, the American College of Cardiology’s 62nd Annual Scientific Session, leading cardiologists presented that the use of dabigatran following ablation for atrial fibrillation resulted in no major post-procedural complications.

Boehringer Ingelheim announced results demonstrating that its investigational fully humanized antibody fragment (Fab) rapidly reversed the anticoagulation effect of dabigatran in healthy male volunteers.

For patients with venous thromboembolism, extended treatment with dabigatran is noninferior to warfarin.

Linked to lower risk of intracranial bleeding, but higher risk of gastrointestinal bleeding

Dabigatran Etexilate Capsules is a direct thrombin inhibitor indicated to reduce the risk of stroke and blood clots.

Boehringer Ingelheim has announced that Praxbind, a reversal agent for the oral anticoagulant Pradaxa (dabigatran etexilate mesylate), is now available in over 2,200 hospitals across the U.S